ES537575A0 - Procedimiento para la fabricacion de fosfatidilserina para el tratamiento de desordenes del sistema nervioso central - Google Patents

Procedimiento para la fabricacion de fosfatidilserina para el tratamiento de desordenes del sistema nervioso central

Info

Publication number
ES537575A0
ES537575A0 ES537575A ES537575A ES537575A0 ES 537575 A0 ES537575 A0 ES 537575A0 ES 537575 A ES537575 A ES 537575A ES 537575 A ES537575 A ES 537575A ES 537575 A0 ES537575 A0 ES 537575A0
Authority
ES
Spain
Prior art keywords
nervous system
central nervous
phosfatidilserine
procedure
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES537575A
Other languages
English (en)
Other versions
ES8608528A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Publication of ES537575A0 publication Critical patent/ES537575A0/es
Publication of ES8608528A1 publication Critical patent/ES8608528A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Resins (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heat Treatment Of Steel (AREA)
ES537575A 1983-11-17 1984-11-12 Procedimiento para la fabricacion de fosfatidilserina para el tratamiento de desordenes del sistema nervioso central Expired ES8608528A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT49355/83A IT1212900B (it) 1983-11-17 1983-11-17 Uso terapeutico della fosfatidilserina in malattie del sistema nervoso centrale senza effetti sulla coagulazione sanguigna

Publications (2)

Publication Number Publication Date
ES537575A0 true ES537575A0 (es) 1986-07-16
ES8608528A1 ES8608528A1 (es) 1986-07-16

Family

ID=11270453

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537575A Expired ES8608528A1 (es) 1983-11-17 1984-11-12 Procedimiento para la fabricacion de fosfatidilserina para el tratamiento de desordenes del sistema nervioso central

Country Status (25)

Country Link
US (1) US4595680A (es)
EP (1) EP0148045B1 (es)
JP (1) JPH0676334B2 (es)
KR (1) KR870001330B1 (es)
AT (1) ATE35415T1 (es)
AU (1) AU572228B2 (es)
BE (1) BE901074A (es)
CH (1) CH661734A5 (es)
DE (1) DE3472406D1 (es)
DK (1) DK168271B1 (es)
ES (1) ES8608528A1 (es)
FI (1) FI79946C (es)
FR (1) FR2555050B1 (es)
GR (1) GR80951B (es)
HU (1) HU193302B (es)
IE (1) IE58130B1 (es)
IL (1) IL73420A (es)
IN (1) IN162717B (es)
IT (1) IT1212900B (es)
LU (1) LU85639A1 (es)
MX (1) MX160792A (es)
NO (1) NO164275C (es)
NZ (1) NZ210091A (es)
PT (1) PT79510B (es)
ZA (1) ZA848776B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471776A1 (fr) * 1979-12-21 1981-06-26 Oreal Nouveaux agents cosmetiques a base de polymeres cationiques, compositions cosmetiques les contenant, et leur application
IT1213034B (it) * 1986-02-12 1989-12-07 Istituto Chemioterapico Di Lod Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
US5314695A (en) * 1990-11-13 1994-05-24 Corvas International, Inc. Tissue factor based prothrombin time reagent
FR2673512B1 (fr) * 1991-03-05 1993-08-20 Inst Rech Biolog Sa Nouvelles compositions dietetiques a base de lipides complexes phosphores et leur utilisation dans les troubles du sommeil.
IT1247165B (it) * 1991-03-15 1994-12-12 Fidia Spa Uso terapeutico della fosfatidilserina e derivati in patologie degenerative anche associate a disfunsioni immunitarie.
IT1248012B (it) * 1991-06-07 1995-01-05 Mediolanum Farmaceutici Spa Impiego del fosfatidilinositolo per la terapia dei disturbi della depressione.
IT1260149B (it) * 1992-04-17 1996-03-28 Fidia Spa Metodo per la preparazione e purificazione di miscele di fosfolipidi prive di contaminanti da virus non convenzionali
GB9621293D0 (en) * 1996-10-11 1996-11-27 Scotia Holdings Plc Formulations containing unsaturated fatty acids
US20030147944A1 (en) * 1999-12-10 2003-08-07 Mayer Lawrence D Lipid carrier compositions with protected surface reactive functions
US7226916B1 (en) * 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
CA2319928A1 (en) 2000-09-18 2002-03-18 Vasogen Ireland Limited Apoptosis-mimicking synthetic entities and use thereof in medical treatments
TWI281407B (en) * 2000-09-18 2007-05-21 Vasogen Ireland Ltd Apoptosis-mimicking synthetic entities and use thereof in medical treatment
US6676963B1 (en) * 2000-10-27 2004-01-13 Barnes-Jewish Hospital Ligand-targeted emulsions carrying bioactive agents
CN1625406A (zh) * 2001-08-09 2005-06-08 底古萨食品配料有限公司 用于预防和治疗温血动物的应激状态的含有溶血磷脂酰丝氨酸的制剂
JP4599604B2 (ja) * 2002-04-19 2010-12-15 カーギル テクスチュアライジング ソリューションズ ドイチュラント ゲゼルシャフト ミット ベシュレクテル ハフツング ウント コンパニー コマンディートゲゼルシャフト 生体活性のリン脂質含有成分を含有するマトリックス
US6878532B1 (en) 2003-04-28 2005-04-12 Sioux Biochemical, Inc. Method of producing phosphatidylserine
CN1308334C (zh) * 2004-06-01 2007-04-04 山东师范大学 一种从动物脑提取磷脂酰丝氨酸的方法
IL182372A0 (en) * 2007-04-01 2008-01-20 Enzymotec Ltd Compositions containing phosphatidylserine in treating diabetes-associated conditions
ITMI20121784A1 (it) * 2012-10-22 2014-04-23 Velleja Res Srl Composizioni galattogeniche a base di fosfatidilserina
US20160317560A1 (en) * 2013-11-07 2016-11-03 The University Of North Carolina At Chapel Hill Particles containing phospholipids or bioactive fatty acids and uses thereof
IT202100032252A1 (it) * 2021-12-22 2023-06-22 Fidia Farm Spa Processo di estrazione e purificazione industriale di fosfolipidi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3156616A (en) * 1958-11-14 1964-11-10 Canada Majesty In Right Of Composition and method for correcting foods and blood conditions having clot promoting characteristics
US3436413A (en) * 1965-12-21 1969-04-01 Canada Packers Ltd Process for the isolation of phosphatidyl serine
FR5060M (es) * 1965-12-22 1967-05-08
US4078052A (en) * 1976-06-30 1978-03-07 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Large unilamellar vesicles (LUV) and method of preparing same
JPS55115824A (en) * 1979-02-28 1980-09-06 Nippon Shoji Kk Remedy for clouding of consciousness and sensomobile disorder

Also Published As

Publication number Publication date
IE842785L (en) 1985-05-17
HUT35957A (en) 1985-08-28
EP0148045A1 (en) 1985-07-10
AU572228B2 (en) 1988-05-05
GR80951B (en) 1984-12-18
PT79510B (en) 1986-09-08
ES8608528A1 (es) 1986-07-16
FI79946C (fi) 1990-04-10
IT1212900B (it) 1989-11-30
IT8349355A0 (it) 1983-11-17
NZ210091A (en) 1988-06-30
DK168271B1 (da) 1994-03-07
MX160792A (es) 1990-05-17
NO164275C (no) 1990-09-19
FI79946B (fi) 1989-12-29
EP0148045B1 (en) 1988-06-29
CH661734A5 (fr) 1987-08-14
JPH0676334B2 (ja) 1994-09-28
IL73420A0 (en) 1985-02-28
KR850003504A (ko) 1985-06-20
FI844468L (fi) 1985-05-18
US4595680A (en) 1986-06-17
NO844585L (no) 1985-05-20
IL73420A (en) 1988-06-30
NO164275B (no) 1990-06-11
PT79510A (en) 1984-12-01
KR870001330B1 (ko) 1987-07-18
BE901074A (nl) 1985-05-17
DK524884A (da) 1985-05-18
AU3563084A (en) 1985-05-30
DE3472406D1 (en) 1988-08-04
DK524884D0 (da) 1984-11-02
FI844468A0 (fi) 1984-11-14
ATE35415T1 (de) 1988-07-15
IN162717B (es) 1988-07-02
LU85639A1 (fr) 1985-06-04
ZA848776B (en) 1986-06-25
HU193302B (en) 1987-09-28
IE58130B1 (en) 1993-07-14
FR2555050B1 (fr) 1986-12-26
FR2555050A1 (fr) 1985-05-24
JPS60132921A (ja) 1985-07-16

Similar Documents

Publication Publication Date Title
ES537575A0 (es) Procedimiento para la fabricacion de fosfatidilserina para el tratamiento de desordenes del sistema nervioso central
ES542323A0 (es) Un procedimiento para la preparacion de derivados de la 2 pirimidinil-1-piperazina
IL76700A0 (en) Pharmaceutical compositions containing liposomes of synthetic lipids and their manufacture
ES8600060A1 (es) Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros.
DE3479189D1 (en) Pharmaceutical composition with special 1,2-diacyl-glycero-3-phosphocholines for the treatment of diseases of the stomach and the intestines
ATE47035T1 (de) Kit oder vorrichtung und methode zum verabreichen von gangliosiden und deren derivate durch inhalation und dafuer geeignete pharmazeutische zusammensetzungen.
ES2098207T1 (es) Producto para el cuidado de la piel y procedimiento de utilizacion.
ATE59295T1 (de) Prazosin-pirbuterol-mischung zur bronchendilatation.
ES8707111A1 (es) Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas.
ES534859A0 (es) Procedimiento para la obtencion de derivados de 1-(4'-alquilsulfonilfenil)-2-amino-1,3-propandiol n-substituidos
ES2055440T3 (es) Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.
ES8404979A1 (es) Procedimiento para la obtencion de esteres del acido carbamico
GT198400156A (es) Derivados de dihidropenzopiranos.
ES532438A0 (es) Procedimiento para preparar 2-alquiltio-1-amino-alquil-2-pirrolin-3-carbonitrilos

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970701